Role of TRP Channels in Cancer-Induced Bone Pain

Area of Science:

• Oncology
• Pain Medicine
• Molecular Biology

Background:

• Cancer burden is increasing globally, with bone metastases significantly impacting patient prognosis and quality of life.
• Cancer-induced bone pain (CIBP) management presents unmet needs, and current opioid treatments have significant side effects.
• Advances in cancer treatment have increased patient survival, highlighting the need for better long-term pain management.

Purpose of the Study:

• To review the role of Transient Receptor Potential (TRP) channels in cancer pain models.
• To explore the potential of TRP channel modulators as novel analgesic strategies for CIBP.
• To discuss the implications of TRP channel function in bone remodeling and pain perception.

Main Methods:

• Narrative review of existing literature on TRP channel function in cancer pain.
• Analysis of preclinical data from genetic deletion studies and TRP channel modulator investigations.
• Examination of the physiological role of TRP channels in bone remodeling.

Main Results:

• TRP channels are involved in cancer cell functions, including metastasis, and in pain perception pathways.
• Genetic deletion of TRP channels reduced pain sensitivity in tumor cell inoculation models.
• Preclinical data support TRP channel modulators (e.g., TRPV1, TRPA1, TRPM7, TRPM8) as potential analgesics.

Conclusions:

• TRP channels are promising targets for innovative CIBP management strategies.
• Modulating TRP channels may offer an alternative to opioids, mitigating their adverse effects.
• Further clinical research is needed to validate TRP channel modulators for cancer pain treatment.